UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008816
Receipt number R000008553
Scientific Title The study of the amount of laser irradiation in photodynamic therapy for exudative age-related macular degeneration
Date of disclosure of the study information 2012/09/10
Last modified on 2014/10/06 07:15:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of the amount of laser irradiation in photodynamic therapy for exudative age-related macular degeneration

Acronym

The study of the amount of laser irradiation in photodynamic therapy

Scientific Title

The study of the amount of laser irradiation in photodynamic therapy for exudative age-related macular degeneration

Scientific Title:Acronym

The study of the amount of laser irradiation in photodynamic therapy

Region

Japan


Condition

Condition

age-related macular degeneration

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety with the amount of laser irradiation in photodynamic therapy for age-related macular degeneration

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Variation on a logarithm of the minimum angle resolution of 12 months after the initial photodynamic therapy

Key secondary outcomes

To assess complication of 12 months after the initial photodynamic therapy and examine retinal angiography and retinal thickness


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Standard-fluence photodynamic therapy

Interventions/Control_2

Reduced-fluence photodynamic therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

treatment naive age-related macular degeneration with subfoveal choroidal neovascularization with visual acuity from 0.1 to 0.5

Key exclusion criteria

choroidal neovascularization secondary to pathological myopia and other disease

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenichi Mizukawa

Organization

Kawasaki Medical School Hospital

Division name

Ophthalmology

Zip code


Address

577 Matsshima, Kurashiki, Okayama 701-0192, Japan

TEL

086-462-1111

Email

mizu-p@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kenichi Mizukawa

Organization

Kawasaki Medical School Hospital

Division name

Ophthalmology

Zip code


Address

577 Matsshima, Kurashiki, Okayama 701-0192, Japan

TEL

086-462-1111

Homepage URL


Email

mizu-p@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 05 Month 02 Day

Date of IRB


Anticipated trial start date

2012 Year 05 Month 23 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 08 Month 31 Day

Last modified on

2014 Year 10 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008553


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name